Home » Prices » NASDAQ:CLRB

Cellectar Biosciences, Inc. stock price

Today's NASDAQ:CLRB chart, history & news

Price:
1.23 USD
Change:
+0.02 (1.65%)
Key Stats
Price open 1.22
Previous close 1.21
Market cap 32.98M
Volume 120.74K
Day high 1.27
Day low 1.22
Year high 3.17
Year low 1.03
Year to date change -48.95%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Cellectar Biosciences, Inc.

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.

Company information

Company name
Cellectar Biosciences Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
8
CEO
James V. Caruso
Address
100 Campus Drive, Florham Park, NJ, 07932
Country
United States
Contact information
1.608.441.8120
Website
http://www.cellectar.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.